In an effort to get quality medicines both within and post the Covid-19 pandemic, the National Institute of Pharmaceutical Research and Development (NIPRD), has signed a Memorandum of Understanding (MoU) with Bloom Public Health.
Bloom Public Health concept was born from the need to create strategic and operational solutions at the African level for public health problems and, particularly, in the pharmaceutical sector.
The partnership between NIPRD and Bloom is aimed at strengthening the capacity of NIPRD on research and development of pharmaceuticals to ensure the availability of quality medicines to all Nigerians during and post the Covid-19 pandemic.
In a press statement in Abuja on Monday, Bloom said it would will facilitate other collaborations within Africa to support NIPRD in playing a leadership role in the pharmaceutical quality space.
In addition, Bloom will also serve as NIPRD’s technical partner for accessing and implementing donor funded initiatives to enhance NIPRD’s impact in Nigeria.
The statement quoted the Chief Executive Officer (CEO) of Bloom Public Health, Prof. Chimezie Anyakora, as saying that: “The Covid-19 pandemic amplifies the urgent need to strengthen the Nigerian Pharmaceutical sector and NIPRD as an institution is extremely instrumental to the growth and development of the sector.
“This partnership will ensure that NIPRD is fully supported technically to lead our country’s pharmaceutical sector reform and we are honored and privileged to be able to contribute our quota to this great journey.
“The Bloom Public Health and NIPRD partnership will catalyze a pharmaceutical renaissance and we are looking forward to the impact it will have on public health.”
On his part, the Director General NIPRD, Dr. Obi Peter Adigwe, noted that, “the partnership between Bloom and NIPRD is the type of Africa-led collaboration that will revolutionize the development of home-grown solutions for our healthcare issues.
“With NIPRD being one of a kind in the region and also statutorily charged with the responsibility for research and development of drugs, vaccines, phytomedicines and commodities, our strategic plan is to use carefully nurtured partnerships with institutions, Nigerian and Foreign universities and funding agencies to stimulate local production of excipients, pharma inputs, quality medicines and other innovative interventions for the sector.
“We are glad to partner with Bloom Public Health as it is just the sort of contextual alliance that can expedite access to healthcare for our people”.
